Patient Power
Investigators are studying the cancer risks related to high and low Immunoglobulin A (IgA) levels. Andrew Kin, M.D., hematologist and medical oncologist, and member of the Bone Marrow & Stem Cell Transplant, Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, discussed what certain levels of IgA may indicate, including conditions other than cancer.
Read the article here.